Back to results
US 2002/0054851 A1Published application
32P-Polyphosphazenes
OwnerMichael Grunze, Alexander Welleinventors
Life of this patent
Estimating the term…
Abstract
The invention concerns a radio-labeled antithrombogenic polymer and its use as part of therapeutic means to prevent excessive cell proliferation or scarring, and means which comprise the radiolabeled antithrombogenic polymer, such as emplastrum or artificial implants with a biocompatible coating.
Claims18
Antithrombogenic polymer with the following general formula (I)
- 2
- in which
- n stands for 2 to ∞,
- R1 to R6 are the same or different and mean an alkoxy, alkylsulfonyl, dialkylamino or aryloxy group or a heterocycloalkyl or heteroaryl group with nitrogen as the heteroatom, and
- in which at least part of the polymer chain of the antithrombogenic polymer has a radioactively labeled component.
2 more elements
Dependencies are inferred from the claim text.